41 days ago
Some folks are prolific liars. Some folks cheer on prolific liars and some folks get attacked for being a good guy who exposes prolific liars. If you believe that I am the source of all evil like crazy Meg Short at Bloomberg and so deserve to be “destroyed”, here is yet more evidence that I am a good guy and that you are just plain wrong and stupid and a disgrace to your profession.
49 days ago
The report and interims are out. I discuss my role in exposing this fraud via the FRC, the nature of the fraud and why the PROLIFIC LIAR and FRAUDSTER Stuart Ashman should be in jail, what is being covered up or not said, why more heads should roll, the interims, current trading and again what is NOT being disclosed, the risks of a placing and the now current valuation of Skinbiotherapeutics (SBTX).
60 days ago
As I have noted many times, to hoots of derision from small furry rodents, Stuart Ashman’s fanboys and other denialists, if the only matter being investigated by FRP at Skinbiotherapeutics (SBTX) was the fraudulent recognition of accrued income from Croda, thus investigation which started in mid February would have been over by March. Today we have an update.
147 days ago
Any suggestion from the denialists that Skinbiotherapeutics (SBTX) might have over egged the extent of the crimes of disgraced prolific liar and fraudster Stuart Ashman and that there might be a kiss and make up are today put to bed with news that Rachel Parsonage has been appointed as interim CEO. She appears to have a cracking CV but..
152 days ago
It is not a major thing but it raises two issues. On 5th December in an RNS Skinbiotherapeutics (SBTX) promised that its shareholders could quiz the company in an Investor Meet (IMC) session in January. Now Stuart Ashman might, as is his wont, accuse me of being a prolific liar in stating this but you can check out the announcement and I am telling the truth. As for Ashman…
163 days ago
The failure of SkinBiotherapeutics (SBTX) to say why Stuart Ashman had been suspended before he resigned as CEO means that there can be no certainty as to the financial position of the company or the veracity of past claims made by Ashman and, as such, anyone buying shares is terribly brave. They may be rewarded they may not be, we shall see. But in thus void there are some crazy theories doing the rounds. A lawyer writes.
227 days ago
I consider today's developments at Versarien (VRS) whose former CEO repeatedly accused me of lying, Skinbiotherapeutics (SBTX) whose CEO's homework has just been marked as a fail by Sam Antar and Nightcap (NGHT) and all the red flags flying today.
227 days ago
The audio clip below is from an interview conducted by a small furry rodent and Stuart Ashman the CEO at Skinbiotherapeutics (SBTX). Natch the defamatory statement is not corrected or challenged by the rodent.